ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,275.52
-0.15%
US Tech 100
18,100.00
-0.14%
다우존스 지수
38,641.07
0.18%
Bitcoin
70,539.41
2.52%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Avant Immunotherapeutics (MM) (AVAN)

  7. Avant Immunotherapeutics (MM) (AVAN) 뉴스

AVAN

Avant Immunotherapeutics (MM) (AVAN)

Avant Immunotherapeutics (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AVAN
일자시간출처헤드라인심볼기업
2008/09/3006:02Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:43Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:42Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:41Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/3000:41Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/2921:00Business WireAVANT Immunotherapeutics Announces Name Change to Celldex TherapeuticsNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/2407:14Edgar (US Regulatory)Avant Immunotherapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/1923:28Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/09/1905:00Business WireAVANT CEO To Present at the UBS 2008 Global Life Sciences Conference September 23NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/1405:53Edgar (US Regulatory)Avant Immunotherapeutics Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/0905:16Business WireAVANT CEO to Present at the 28th Annual Canaccord Adams Global Growth ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/0623:52Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/0621:46Business WireCORRECTING and REPLACING AVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/0621:00Business WireAVANT Reports Second Quarter and Six Month Financial ResultsNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/08/0502:56Business WireAVANT to Report Second Quarter 2008 Financial Results on August 6, 2008NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/07/2906:25Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/07/1905:59Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/07/1903:05Edgar (US Regulatory)Avant Immunotherapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/2705:47Edgar (US Regulatory)Avant Immunotherapeutics Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/1900:13Edgar (US Regulatory)Avant Immunotherapeutics Inc - Securities Registration: Employee Benefit Plan (S-8)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/1121:00Business WireAVANT Announces Vaccine Adjuvant Licenses with 3MNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/1005:29Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/0423:00Business WireAVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology ConferenceNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/0420:00Business WireNIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera VaccineNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/0321:30MarketwiredMarket Pulse Breaking News Alert for Tuesday, June 3, 2008: NCEN – NACEL Energy Achieves Objectives With 640 MW Wind Power in DeNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/0305:56Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
2008/06/0303:32MarketwiredNew Analyst Reports for AVANT IMMUNOTHERAPEUTICS, CANADIAN SOLAR INC, LIBERTY MEDIA HOLDING CORPORATION, and BED BATH AND BEYONDNASDAQ:AVANAvant Immunotherapeutics (MM)
2008/05/3102:54Edgar (US Regulatory)Avant Immunotherapeutics Inc - Current report filing (8-K)NASDAQ:AVANAvant Immunotherapeutics (MM)
 검색 관련기사 보기:NASDAQ:AVAN

최근 히스토리

AMEX
XLF
Financial Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US100
US Tech 100
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
NYSE
CVX
Chevron
FX
USDEUR
US Dollar vs Euro
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유